Lifestyle modification program, LIFE is LIGHT, in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week, multicenter, non‐randomized, parallel‐group, open‐label study-Reference-Cited by-同舟云学术

Lifestyle modification program, LIFE is LIGHT, in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week, multicenter, non‐randomized, parallel‐group, open‐label study

Published:2021-04-09 Issue:4 Volume:7 Page:368-378
ISSN:2055-2238
Container-title:Obesity Science & Practice
language:en
Short-container-title:Obes Sci Pract

Author:

Galstyan Gagik R.¹,Valeeva Farida V.²,Motkova Svetlana I.¹,Surkova Elena V.¹,Savelyeva Larisa V.¹,Rudina Larisa M.³,Ramanathan Krishnan⁴,Sokareva Ekaterina⁵,Bondareva Kristina⁶,Shestakova Marina V.¹

Affiliation:

1. Endocrinology Research Centre Moscow Russia

2. Kazan State Medical University Kazan Russia

3. The Russian Presidential Academy of National Economy and Public Administration Moscow Russia

4. Novartis Pharma Basel Switzerland

5. Novartis Pharma LLC Moscow Russia

6. Almedis Moscow Russia

Funder

Novartis

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/osp4.502

Reference33 articles.

1. Medical Research Council.Diabetes: Facts and Stats.https://mrc.ukri.org/documents/pdf/diabetes‐uk‐facts‐and‐stats‐june‐2015/. Accessed September 11 2020.

2. The therapeutics of lifestyle management on obesity

3. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study)

4. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019

5. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)